Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?2.9mm SC, SLActive? 10mm, RXD, Loxi: medical device reports filed with FDA

7,118 reports name it, 2018–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

7,118
device reports naming the brand
0% of all MAUDE reports · about 847 a year
1,161
reports, 12 months to August 2026
1,116 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 7,118 reports that name the brand "BLT ?2.9mm SC, SLActive? 10mm, RXD, Loxi" (endosseous dental implant), received between February 2018 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

1,161 reports arrived in the 12 months to August 2026, close to the 1,116 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (75.5%), loss of osseointegration (15.5%) and difficult to insert (1.3%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0114228Sep 2021: 74Oct 2021: 47Nov 2021: 92Dec 2021: 572022Jan 2022: 94Feb 2022: 50Mar 2022: 102Apr 2022: 96May 2022: 92Jun 2022: 70Jul 2022: 63Aug 2022: 92Sep 2022: 57Oct 2022: 71Nov 2022: 88Dec 2022: 942023Jan 2023: 86Feb 2023: 89Mar 2023: 101Apr 2023: 69May 2023: 112Jun 2023: 70Jul 2023: 83Aug 2023: 107Sep 2023: 73Oct 2023: 112Nov 2023: 96Dec 2023: 1002024Jan 2024: 69Feb 2024: 84Mar 2024: 97Apr 2024: 152May 2024: 95Jun 2024: 74Jul 2024: 58Aug 2024: 80Sep 2024: 76Oct 2024: 111Nov 2024: 100Dec 2024: 792025Jan 2025: 68Feb 2025: 98Mar 2025: 121Apr 2025: 53May 2025: 0Jun 2025: 228Jul 2025: 86Aug 2025: 96Sep 2025: 95Oct 2025: 120Nov 2025: 115Dec 2025: 812026Jan 2026: 89Feb 2026: 60Mar 2026: 102Apr 2026: 106May 2026: 75Jun 2026: 103Jul 2026: 112Aug 2026: 103

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

05811,1612018: 27620182019: 46320192020: 53120202021: 79520212022: 96920222023: 1,09820232024: 1,07520242025: 1,16120252026: 7502026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%7,118
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report72.9%5,186
Voluntary report0%0
User facility report0%0
Distributor report27.1%1,932
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate5,37775.5%62.8%
Loss of osseointegration1,10015.5%22.4%
Difficult to insertthe device was hard to insert901.3%0.4%
Fracturea broken bone570.8%1.6%
Separation failure170.2%0.1%
Difficult to removethe device was hard to remove100.1%0%
Unstable30%0%
Therapeutic or diagnostic output failure20%0%
Unintended movement20%0%
Activation, positioning or separation problem10%0%
Defective devicethe device was defective10%0%
Insufficient device problem information10%0.2%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis2,45334.5%
Painpain, site not specified1,37119.3%
Tissue damage89312.5%
Inflammationinflammation6238.8%
Swelling/ edema3975.6%
Hemorrhage/blood loss/bleeding3725.2%
Fistula3695.2%
Abscessa collection of pus2313.2%
Hyperresponsive to stimuli2123%
Swellingswelling681%
Hypersensitivity/allergic reaction530.7%
Failure of implant330.5%
Increased sensitivity250.4%
Inadequate osseointegration230.3%
Numbnessnumbness70.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?2.9mm SC, SLActive? 10mm, RXD, LoxiProduct code DZEAll MAUDE reports
Reports7,1183,924,24126,136,888
Share of that pool—0.2%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer72.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?2.9mm SC, SLActive? 10mm, RXD, Loxi reports

How many FDA reports name BLT ?2.9mm SC, SLActive? 10mm, RXD, Loxi?

7,118 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,161 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (75.5%), loss of osseointegration (15.5%), difficult to insert (1.3%), fracture (0.8%) and separation failure (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (72.9%) and distributor reports (27.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?2.9mm SC, SLActive? 10mm, RXD, Loxi was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.